Literature DB >> 18365734

[Synthetic peptide KKRR corresponding to the human ACTH fragment 15-18 is an antagonist of the ACTH receptor].

Iu A Kovalitskaia, A A Kolobov, E A Kampe-Nemm, V V Iurovskií, V B Sadovnikov, V M Lipkin, E V Navolotskaia.   

Abstract

Tritium-labeled synthetic fragments of human adrenocorticotropic hormone (ACTH) [3H]ACTH (11-24) and [3H]ACTH (15-18) with a specific activity of 22 and 26 Ci/mmol, respectively, were obtained. It was found that [3H]ACTH (11-24) binds to membranes of the rat adrenal cortex with high affinity and high specificity (Kd 1.8 +/- 0.1 nM). Twenty nine fragments of ACTH (11-24) were synthesized, and their ability to inhibit the specific binding of [3H]ACTH (11-24) to adrenocortical membranes was investigated. The shortest active peptide was found to be an ACTH fragment (15-18) (KKRR) (Ki 2.3 +/- 0.2 nM), whose [3H] labeled derivative binds to rat adrenocortical membranes (Kd 2.1 +/- 0.1 nM) with a high affinity. The specific binding of [3H]ACTH-(15-18) was inhibited by 100% by unlabeled ACTH (11-24) (Ki 2.0 +/- 0.1 nM). ACTH (15-18) in the concentration range of 1-1000 nM did not affect the adenylate cyclase activity of adrenocortical membranes and, therefore, is an antagonist of the ACTH receptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365734

Source DB:  PubMed          Journal:  Bioorg Khim        ISSN: 0132-3423


  3 in total

1.  Approaches to the rational design of selective melanocortin receptor antagonists.

Authors:  Victor J Hruby; Minying Cai; Joel Nyberg; Dhanasekaran Muthu
Journal:  Expert Opin Drug Discov       Date:  2011-03-24       Impact factor: 6.098

2.  Autoantibodies reactive to adrenocorticotropic hormone can alter cortisol secretion in both aggressive and nonaggressive humans.

Authors:  Henning Værøy; Csaba Adori; Romain Legrand; Nicolas Lucas; Jonathan Breton; Caroline Cottard; Jean-Claude do Rego; Céline Duparc; Estelle Louiset; Hervé Lefebvre; Pierre Déchelotte; Elin Western; Stein Andersson; Tomas Hökfelt; Sergueï O Fetissov
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

Review 3.  ACTH Antagonists.

Authors:  Adrian John Clark; Rachel Forfar; Mashal Hussain; Jeff Jerman; Ed McIver; Debra Taylor; Li Chan
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-05       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.